Personalized Antiplatelet Strategies: State of the Art
Description: Paul Gurbel, MD discusses platelet function testing and the continuing personalization of antiplatelet therapies such as clopidogrel, prasugrel and ticagrelor in order to optimize clinical outcomes. Includes several cases. Presented live at the 2012 Case-Oriented Symposium on Bleeding and Thrombosis in Arlington, VA.
Learning objectives — at the conclusion of this program participants will be able to:
• Review the mechanism of action of P2Y12 inhibitors and other antiplatelet drugs
• Review clinical data and relations of platelet function to thrombosis and bleeding
ASCLS P.A.C.E. credits available through April 13, 2013.